Steven M Camp

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Sorry, we do not have enough data to show an influence graph for this author.
Learn More
Novel therapies are needed to address the vascular endothelial cell (EC) barrier disruption that occurs in inflammatory diseases such as acute lung injury (ALI). We previously demonstrated the potent(More)
Herpes simplex virus type 1/adeno-associated virus (HSV/AAV) rep+ hybrid amplicon vectors containing AAV inverted terminal repeats (ITRs) and rep gene sequences can mediate site-specific integration(More)
Mutations in the lysosomal acid beta-galactosidase (EC underlie two different disorders: GM1 gangliosidosis, which involves the nervous system and visceral organs to varying extents, and(More)